City Therapeutics, Inc.

City Therapeutics, Inc. financial statements

City Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 13.56MEODHD
Net income−USD 58.51MEODHD
Cash and equivalentsUSD 112.79MEODHD

City Therapeutics, Inc. financials on 6ix · City Therapeutics, Inc. on 6ix